Glenmark Pharmaceuticals Q4 Results
- BSE: 532296
- NSE: GLENMARK
- ISIN: INE935A01035
- Sector: Biotechnology & Drugs
BSE
1,493.45
13.40 (0.91%)
13.40 (0.91%)Volume12.74 K
Updated: Mon 25 Nov, 2024 | 15:29:00
NSE
1,490.412.20 (0.83%)
12.20 (0.83%)Volume8.17 L
Updated: Mon 25 Nov, 2024 | 15:31:30
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Glenmark Pharmaceuticals Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 24 | Dec 22 | QoQ Comp | Mar 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 3,062.95 | 3,100.18 | -% | 11,583.24 | -% |
| Selling/ General/ Admin Expenses Total | 700.96 | 707.46 | -% | 2,600.78 | -% |
| Depreciation/ Amortization | 151.34 | 151.51 | -% | 569.17 | -% |
| Other Operating Expenses Total | 862.13 | 852.24 | -% | 3,089.92 | -% |
| Total Operating Expense | 3,156.73 | 2,743.78 | -% | 11,283.26 | -% |
| Operating Income | -93.78 | 356.40 | -% | 299.98 | -% |
| Net Income Before Taxes | 530.83 | 329.86 | -% | 239.84 | -% |
| Net Income | -1,218.28 | 272.58 | -% | 297.25 | -% |
| Diluted Normalized EPS | -33.74 | 5.26 | -% | 11.62 | -% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
- Markets
01NTPC Green Energy IPO allotment date likely today. GMP, how to check status online
2 min read07:58 AM IST - Markets
02Buy or sell: Sumeet Bagadia recommends three stocks to buy on Monday — Nov 25
4 min read06:15 AM IST - Markets
03Enviro Infra Engineers IPO day 2: GMP jumps; subscription status, review, apply or not?
3 min read03:07 PM IST